Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

被引：31

作者：

Jelinek, Tomas ^{[1
,2
]}

Sevcikova, Tereza ^{[1
,2
]}

Zihala, David ^{[1
,2
]}

Popkova, Tereza ^{[1
,2
]}

Kapustova, Veronika ^{[1
,2
,3
]}

Broskevicova, Lucie ^{[1
,2
]}

Capkova, Lenka ^{[4
]}

Rihova, Lucie ^{[5
]}

Bezdekova, Renata ^{[5
]}

Sevcikova, Sabina ^{[6
]}

Zidlik, Vladimir ^{[7
]}

Havel, Martin ^{[8
]}

Plonkova, Hana ^{[1
,2
]}

Jungova, Alexandra ^{[9
]}

Minarik, Jiri ^{[10
,11
]}

Stork, Martin ^{[12
,13
]}

Pour, Ludek ^{[12
,13
]}

Pavlicek, Petr ^{[14
]}

Spicka, Ivan ^{[15
,16
]}

Maisnar, Vladimir ^{[17
]}

Radocha, Jakub ^{[17
]}

Simicek, Michal ^{[1
,2
]}

Hajek, Roman ^{[1
,2
]}

机构：

[1] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[2] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[3] Univ Ostrava, Fac Med, Dept Biol & Ecol, Ostrava, Czech Republic

[4] Inst Biostat & Analyses Ltd, Brno, Czech Republic

[5] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic

[6] Masaryk Univ, Fac Med, Dept Pathofysiol, Babak Myeloma Grp, Brno, Czech Republic

[7] Univ Hosp Ostrava, Dept Pathol, Ostrava, Czech Republic

[8] Univ Hosp Ostrava, Dept Nucl Med, Ostrava, Czech Republic

[9] Charles Univ Hosp Pilsen, Hematol & Oncol Dept, Czechia, Czech Republic

[10] Univ Hosp Olomouc, Dept Hematooncol, Czechia, Czech Republic

[11] Palacky Univ Olomouc, Fac Med & Dent, Czechia, Czech Republic

[12] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Czechia, Czech Republic

[13] Masaryk Univ, Fac Med, Czechia, Czech Republic

[14] Univ Hosp Kralovske Vinohrady, Dept Internal Med & Hematol, Prague, Czech Republic

[15] Charles Univ Prague, Fac Med 1, Clin Dept Haematol, Med Dept 1, Prague, Czech Republic

[16] Charles Univ Prague, Gen Teaching Hosp, Prague, Czech Republic

[17] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic

来源：

LEUKEMIA | 2022年 / 36卷 / 01期

关键词：

D O I：

10.1038/s41375-021-01343-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：288 / 291

页数：4

共 15 条

[1] Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
Al Emran, Abdullah
Chatterjee, Aniruddha
Rodger, Euan J.
Tiffen, Jessamy C.
Gallagher, Stuart J.
Eccles, Michael R.
Hersey, Peter
[J]. TRENDS IN IMMUNOLOGY, 2019, 40 (04) : 328 - 344
[2] Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study
Bahlis, Nizar J.
Dimopoulos, Meletios A.
White, Darrell J.
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Kaufman, Jonathan L.
Krevvata, Maria
Chiu, Christopher
Qin, Xiang
Okonkwo, Linda
Trivedi, Sonali
Ukropec, Jon
Qi, Ming
San-Miguel, Jesus
[J]. LEUKEMIA, 2020, 34 (07) : 1875 - 1884
[3] Beksac M., 2020, ISATUXIMAB PLUS POMA
[4] Extramedullary multiple myeloma
Bhutani, Manisha
Foureau, David M.
Atrash, Shebli
Voorhees, Peter M.
Usmani, Saad Z.
[J]. LEUKEMIA, 2020, 34 (01) : 1 - 20
[5] DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
Choudhry, Priya
Mariano, Margarette C.
Geng, Huimin
Martin, Thomas G., III
Wolf, Jeffrey L.
Wong, Sandy W.
Shah, Nina
Wiita, Arun P.
[J]. LEUKEMIA, 2020, 34 (03) : 938 - 941
[6] Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Dimopoulos, Meletios A.
Moreau, Philippe
Terpos, Evangelos
Mateos, Maria-Victoria
Zweegman, Sonja
Cooks, Gordon
Delforge, Michel
Hajek, Roman
Schjesvold, Fredrik
Cavo, Michele
Goldschmidt, Hartmut
Facon, Thierry
Einsele, Hermann
Boccadoro, Mario
San-Miguel, Jesus
Sonneveld, Pieter
Mey, Ulrich
[J]. HEMASPHERE, 2021, 5 (02):
[7] Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
Gagelmann, Nico
Eikema, Diderik-Jan
Iacobelli, Simona
Koster, Linda
Nahi, Hareth
Stoppa, Anne-Marie
Masszi, Tamas
Caillot, Denis
Lenhoff, Stig
Udvardy, Miklos
Crawley, Charles
Arcese, William
Mariette, Clara
Hunter, Ann
Leleu, Xavier
Schipperus, Martin
Delforge, Michel
Pioltelli, Pietro
Snowden, John A.
Itala-Remes, Maija
Musso, Maurizio
van Biezen, Anja
Garderet, Laurent
Kroger, Nicolaus
[J]. HAEMATOLOGICA, 2018, 103 (05) : 890 - 897
[8] Monoclonal antibodies - A new era in the treatment of multiple myeloma
Jelinek, Tomas
Hajek, Roman
[J]. BLOOD REVIEWS, 2016, 30 (02) : 101 - 110
[9] The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Moreno, Laura
Perez, Cristina
Zabaleta, Aintzane
Manrique, Irene
Alignani, Diego
Ajona, Daniel
Blanco, Laura
Lasa, Marta
Maiso, Patricia
Rodriguez, Idoia
Garate, Sonia
Jelinek, Tomas
Segura, Victor
Moreno, Cristina
Merino, Juana
Rodriguez-Otero, Paula
Panizo, Carlos
Prosper, Felipe
San-Miguel, Jesus F.
Paiva, Bruno
[J]. CLINICAL CANCER RESEARCH, 2019, 25 (10) : 3176 - 3187
[10] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma
Nijhof, Inger S.
Casneuf, Tineke
van Velzen, Jeroen
van Kessel, Berris
Axel, Amy E.
Syed, Khaja
Groen, Richard W. J.
van Duin, Mark
Sonneveld, Pieter
Minnema, Monique C.
Zweegman, Sonja
Chiu, Christopher
Bloem, Andries C.
Mutis, Tuna
Lokhorst, Henk M.
Sasser, A. Kate
van de Donk, Niels W. C. J.
[J]. BLOOD, 2016, 128 (07) : 959 - 970

← 1 2 →